Julie Clauss

Julie Clauss serves as Chief Operating Officer at Odyssey Therapeutics. Odyssey Therapeutics operates in the research sector with approximately 150.0 employees. The company is headquartered in Cambridge, Massachusetts. Odyssey Therapeutics generates annual revenue of 2000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Mimecast Outlook Microsoft Office 365 CloudFlare Hosting WP Engine Greenhouse.io WordPress.org Google Font API Google Maps (Non Paid Users) Google Maps Google Tag Manager Mobile Friendly Vimeo Gravity Forms Render Remote

biotechnology research autoimmune diseases inflammatory diseases drug discovery small molecule therapeutics protein therapeutics innate immune system adaptive immune response cytokine targeting disease pathology therapeutic candidates remission induction immunobiology preclinical development clinical-stage biotechnology target validation inflammation prevention ripk2 inhibitor irak4 inhibitor tnfr2 therapy transcription factor drugs biopharmaceutical innovation leadership in biotech ai-driven drug development patient outcomes strategic collaborations resilience in drug discovery biologics monoclonal antibodies therapeutic modalities biomarker strategies drug candidates clinical trials regulatory pathway immune modulation therapeutic platforms patient selection mechanism of action therapeutic targets high-throughput screening precision medicine tolerable combination treatments chronic inflammation medicinal chemistry novel therapeutics structural biology genetics in therapy pro-inflammatory cytokines drug development tools biopharmaceutical clinical-stage small molecules od-07656 ulcerative colitis deep remission unmet medical needs immunomodulation oncology signaling pathways strategic collaboration terray therapeutics ai-driven drug discovery healthcare biotechnology patient populations genetic profiling biomarkers chronic conditions innovative therapies scalable model transformative care drug development immunology healthcare solutions patient-centric approach advanced technologies machine learning crispr strategic partnerships market expansion competitive landscape health care health wellness & fitness hospital & health care artificial intelligence information technology & services

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Julie Clauss in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Odyssey Therapeutics.

Julie Clauss's Position in the MessageCEO Database

• •Julie Clauss is 1 of 1 verified executive contact we track at Odyssey Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •41 verified contacts work at research companies in the 150.0 employee range (same size as Odyssey Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Julie Clauss directly?

Julie Clauss's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating Officer at Odyssey Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Julie Clauss work for?

Julie Clauss is Chief Operating Officer at Odyssey Therapeutics, a company in the research sector with 150.0 employees. The company is based in Cambridge, Massachusetts.

Can I pitch or sell to Julie Clauss?

As Chief Operating Officer at Odyssey Therapeutics, Julie Clauss is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Julie Clauss directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Julie Clauss in?

Julie Clauss works in the research industry as Chief Operating Officer at Odyssey Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Julie Clauss's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Julie Clauss's profile is kept up-to-date with the latest available information.

Last updated: July 21, 2026